Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...

One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.

FG-3246 and enzalutamide combination therapy, in biomarker unselected patients with androgen receptor pathway inhibitor (ARPI)-treated, ...

Scientists report landmark "evolutionary double-bind" strategy to overcome treatment resistance in prostate cancer.

In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

Study is the first to directly quantify and validate a method of exploiting the way cancers evolve, both in the lab and through mathematical modelling ...